Arsenic trioxide mechanisms of action--looking beyond acute promyelocytic leukemia.
Carney
Dennis A
DA
Department of Hematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. dennis.carney@petermac.org
D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000494:pharmacology* / Q000627:therapeutic use; D002454:Cell Differentiation / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D010087:Oxides / Q000494:pharmacology* / Q000627:therapeutic use; D017382:Reactive Oxygen Species
D001152:Arsenicals; D010087:Oxides; D017382:Reactive Oxygen Species; D000077237:Arsenic Trioxide